Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target
Canaccord Genuity Reiterates Buy on KORU Medical Systems, Maintains $3 Price Target
Canaccord Genuity 重申買入KORU Medical Systems，維持3美元的目標股價
Canaccord Genuity analyst Caitlin Cronin reiterates KORU Medical Systems (NASDAQ:KRMD) with a Buy and maintains $3 price target.
Canaccord Genuity分析師凱特琳·克羅寧重申了KORU Medical Systems（納斯達克股票代碼：KRMD）的買入並維持3美元的目標股價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。